OOIR: Observatory of International Research

Papers

(The median citation count of Cancer Genetics is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Exploring the role of transcription factor TWIST1 in bladder cancer progression	90
PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas	55
88. Significant association of BRCA1, BRCA2 and TP53 gene polymorphisms with breast cancer risk in Khyber Pakhtunkhwa, Pakistan	46
Comprehensive FISH testing using FFPE tissue microarray of primary lymph node tissue identifies secondary cytogenetic abnormalities in Mantle Cell Lymphoma	35
A mechanistic insight into cancer progression mediated by Nucleoporins	24
A 10-gene-methylation-based signature for prognosis prediction of colorectal cancer	21
24. Methylation sequencing enhances interpretation of clonal hematopoiesis dynamics	18
Interpretative differences of combined cytogenetic and molecular profiling highlights differences between MRC and ELN classifications of AML	18
40. Prioritization of defining and supportive diagnostic variants in pediatric tumors	16
43. Challenges of classifying variants associated with disorders of somatic mosaicism and guideline creation	15
25. Enhancing precision oncology: The value of open-source knowledgebase integration	15
23. Detection of somatic tumor mutations in circulating plasma DNA of patients with sellar and skull base tumors	14
42. Piloting NTRK fusion-specific oncogenicity guidelines: Lessons learned	14
2. Diagnostic next generation sequencing to detect MYD88 L265P in lymphoplasmacytic lymphoma compared to ddPCR	14
76. Automating immunogenomic tumor board decision-making for neoantigen cancer vaccine design	13
11. Developing a robust bioinformatics workflow to support personalized neoantigen vaccine clinical trials	13
69. Expert consensus standardization of FGFR3 SNV oncogenicity classification and interpretation	12
74. Dilemma of selecting the optimal diagnostic test(s) for genetic biomarkers in hematologic malignancies	12
64. A rare finding of triple KRAS mutations with OmniSeq® INSIGHT in a patient with colorectal adenocarcinoma	12
Pan-cancer analysis reveals that CTC1-STN1-TEN1 (CST) complex may have a key position in oncology	11
A Case report: Co-occurrence of IMAGe syndrome and Rhabdomyosarcoma	10
Editorial Board	9
1. Microdeletion 13q12.2 in B cell acute lymphoblastic leukemia: Little but important!	9
A pediatric BAL case with double Ph chromosomes and trisomy 5	9
34. Discovery of circular RNAs through integration of short- and long-read RNA sequencing	8

58. Improving the molecular diagnosis of SBDS-related disorders by identifying rare gene conversion events.	8
28. Detection of small mutations, copy number alterations and structural variations from targeted cfDNA sequencing in cancer	8
51. Discerning cell types and states in spatial transcriptomics data using topic modelling	8
20. Diagnostic utility and lessons learned from deep sequencing vascular malformations	7
34. A molecular and clinicopathologic analysis of primary intracranial sarcomas	7
48. Crowdsourcing expert curation of somatic variants by the ClinGen Somatic Hematologic Cancer Taskforce	7
68. Integrative analysis of genomic and transcriptomic data using RegTools to identify splice-altering mutations within bulk	7
28. Identification of TP53 germline variants in pediatric patients undergoing tumor testing	7
43. Adapting CIViC, a cancer variant interpretation knowledgebase, to support variants in disorders of somatic mosaicism	7
17. Multi-consortia initiative to standardize the representation and curation of oncogenic fusions	7
67. Long noncoding RNAs encoding peptides in cancer	7
29. Launching a CGC initiative to support trainees and early career members: Survey results and analysis	7
49. Clinical validation of Infinium CytoSNP-850K SNP-Array for routine copy number profiling of hematological malignancies	7
60. Panning for neoantigens to demonstrate feasibility of neoantigen vaccines in canine melanoma	7
21. A case of acute myeloid leukemia with gain of two copies of neocentromeric chromosome 11	6
30. Characterization of atypical iAMP21 observed in B-Lymphoblastic Leukemia (B-ALL): a 2.5-year retrospective study from the Mayo Clinic	6
123. Chromosomal microarray assists interpretation of cytogenetic abnormalities in hematopoietic malignancies	6
44. Reevaluation of copy number variant (CNV) classifications in the clinical laboratory setting: challenges, insights, and experiences with a laboratory-initiated process	6
52. Optical genome mapping and SNP microarray: integrated workflow for optimizing analysis of products of conception	6
22. Masked hypodiploid B-Cell Lymphoblastic Leukemia (B-ALL) characterized by SNP microarray in a Li Fraumeni syndrome patient with post therapy karyotype changes	6
38. A rare constitutional 13q deletion associated with retinoblastoma and chronic lymphocytic leukemia	6
121. Single cell TCR sequencing identifies an enriched V(D)J repertoire in canine melanoma	6
51. PS4 utilization for PIK3CA variants implicated in disorders of somatic mosaicism	6
23. Incidental findings on XON array: Our experience over the last two years	6
43. Structural changes characterized by whole genome mate-pair sequencing in a case with ETV6/ABL1 gene fusion and atypical Chronic Myeloid Leukemia	6
35. Frequencies of Turner syndrome abnormalities as detected by high resolution chromosomal microarray in products of conception and postnatal blood samples	6
135. Tumor deconvolution using comprehensive single-cell RNA sequencing cell type signatures	5
High frequency of BCL2 gene rearrangement-negative follicular lymphoma in northwestern Italy	5
9. Implementation survey of the ACMG/CGC standards for interpretation of acquired CNAs and CN-LOH in neoplastic disorders	5
32. Genetic testing for individuals with non-syndromic differences in sex development (DSD): collaborative approach yields results	5
13. HPV forms chimeric virus-human transcripts that affect host gene expression in cervical tumors	5
Editorial Board	5
4. ETV6-ABL1 variant rearrangement described in a childhood ALL patient	5
Detecting the “undetectable” alterations: Use of NGS to uncover high-risk alterations	5
33. Variability in sex and phenotype: Impact of a familial pathogenic DHX37 variant leading to 46,XY gonadal dysgenesis	5
134. Novel fusions in aggressive infant sarcomas: Expanding the scope of 'CIC-rearranged' sarcoma without CIC rearrangement	5
Editorial Board	5
14. Prenatal diagnosis of Acrofacial Dysostosis type 1 (Nager syndrome) by chromosomal microarray at the exon level	5
Standardized evidence-based approach for assessment of oncogenic and clinical significance of NTRK fusions	5
76. Von Hippel-Lindau syndrome in a patient with negative germline testing	5
50. Analysis of gene rearrangements in neoplasms with Hi-C sequencing using fresh-frozen and FFPE specimens	4
83. Cytogenetic and molecular characterization of IDH-mutant adult-type diffuse gliomas with near-total 1p/19q co-deletions	4
89. TCF3::ZNF384 in a Peruvian girl with mixed-phenotype acute leukemia and poor treatment outcome	4
96. A unique case presentation of pediatric spinal ependymoma with chromothripsis of chromosome 6: case report	4
41. Resolving ambiguities in copy number variation representation	4
23. Optical genome mapping reveals new insights into ZFTA fusion in supratentorial ependymomas	4
81. Prediction of plant based EGFR inhibitors against breast cancer (EGFR) using machine learning model	4
Upregulation of shelterin and CST genes and longer telomeres are associated with unfavorable prognostic characteristics in prostate cancer	4
27. Five-year experience of evaluating individuals at-risk for underlying genetic predisposition to hematologic malignancy	4
42. Automated deep aberration detection from chromosome karyotype images	4

17. Djerba: A modular system to generate clinical genome interpretation reports for cancer	4
90. Genetic biomarkers in pediatric B-cell acute lymphoblastic leukemia detected by NGS in a Peruvian population	4
18. Investigation of pathogenic and truncated variants of RUNX1 and DDX41 in All of Us	4
30. Chromosomal microarray analysis work-up for hypocellular MDS patients with inconclusive cytogenetics	4
48. Targeted RNA-Seq on fresh frozen and methanol/acetic acid fixed cells in diagnostic workup of hematologic malignancies	3
64. Utilizing rapid molecular testing to reduce disparities in pediatric cancer in Sub-Saharan Africa	3
Unfolded protein response signature unveils novel insights into breast cancer prognosis and tumor microenvironment	3
Selection for or against escape from nonsense mediated decay is a novel signature for the detection of cancer genes	3
MUC16 mutation is associated with tumor grade, clinical features, and prognosis in glioma patients	3
Case report of a man with multiple paragangliomas and pathogenic germline variants in both NF1 and SDHD	3
Editorial Board	3
Jumping translocation involving chromosome 13q in a patient with Crohn's Disease and inv(16)(p13.1q22)/CBFB-MYH11 acute myeloid leukemia	3
85. Cell-type-specific genotypic interpretation in the human breast	3
56. Whole-exome sequencing identifies somatic mutations penile squamous cell carcinoma	3
51. Rare SRY-positive derivative X chromosome in female fetus with apparently normal development	3
27. Deregulation and shattering of chromosomal segments containing multiple oncogenic targets in the pathogenesis of diffuse large B cell lymphoma (DLBCL)	3
26. An ATIC::ALK fusion created by balanced insertion rather than inversion of chromosome 2 in an ALK+ anaplastic large cell lymphoma	3
LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185–5p/PLOD1/Akt/mTOR pathway	3
A prognostic gene signature for predicting survival outcome in diffuse large B-cell lymphoma	3
Rare and favorable prognosis of pediatric acute lymphoblastic leukemia with TLS-ERG fusion gene: Case report with long-term follow-up and review of literature	3
Partial tandem duplication of KMT2A gene in patient afflicted with hypereosinophilic syndrome: A case report	3
1. Clinical utility of low-pass whole genome sequencing (LP-WGS) and targeted panel sequencing in liquid biopsies for disease diagnosis and monitoring of patients with pediatric solid tumors	3
49. A novel method for detection of loss of heterozygosity using B-allele frequency from optical genome mapping data	3
66. Screening for genetic predisposition to pediatric leukemia in a Peruvian population	3
54. VMD4Kids: A highly sensitive NGS panel to detect low-level mosaic variants in vascular anomalies and overgrowth disorders	3
11. Structural variation discovery and interpretation in the era of cytogenomics	3
116. Integrating methylation profiling into adult brain tumor diagnostics - the Australian experience	3
Whole-exome sequencing in osteosarcoma with distinct prognosis reveals disparate genetic heterogeneity	3
RNA profile of immuno‐magnetically enriched lung cancer associated exosomes isolated from clinical samples	3
Consensus molecular subtyping of colorectal cancers is influenced by goblet cell content	3
Evaluation of anti-angiogenic agent F16 for targeting glioblastoma xenograft tumors	3
Mast cell leukemia with novel BRAF variant and concomitant atypical KIT variant	3
86. Whole genome sequencing of mouse derived cell-free DNA to develop a NF1-MPNST-PDX liquid biopsy model	3
52. ClinGen Pediatric Cancer Taskforce initiatives to advance pediatric clinical interpretations through expert curation	3
Three FGFR4 gene polymorphisms contribute to the susceptibility of urethral cancer in the middle and south of Iraq population	2
Somatic tumor testing implications for Lynch syndrome germline genetic testing	2
Clonal cytogenetic abnormalities in donor-derived cells after sex mismatched allogeneic stem cell transplantation	2
The prognostic significance of FOXC2 gene expression in cancer: A comprehensive analysis of RNA-seq data from the cancer genome atlas	2
43. Association between Clonal Hematopoiesis and Inherited Cancer Susceptibility Genes	2
Novel Co-frameshift mutations in N- and C-terminal regions of CEBPA in acute myeloid leukemia: A case report	2
8. Harnessing the power of microarray in the analysis of rarer pediatric sarcomas	2
A novel POT1-TPD presentation: A germline pathogenic POT1 variant discovered in a patient with newly diagnosed posterior fossa ependymoma	2
Fibroblast testing can inform medical management in individuals with mosaic variants detected on hereditary cancer panels	2
Dynamics of cell-free DNA in predicting response in adult diffuse glioma on chemoradiotherapy	2
16. International working group recommendations for the implementation of optical genome mapping in Hematologic Malignancies	2
Molecular determinants of clinical outcomes for anaplastic lymphoma kinase–positive non-small cell lung cancer in Chinese patients: A retrospective study	2
Editorial Board	2
Dysregulation of metallothionein MT1 sub-types in TCF3::PBX1 pre-B-cell acute lymphoblastic leukemia	2
A multimodal genomics approach to diagnostic evaluation of pediatric hematologic malignancies	2
31. Rare familial rearrangement with acrocentric satellite material on Yp relocating to Xp in a female fetus	2
Importance of conventional cytogenetics in the identification of ins(19;X)(q13.1;p11.2q28) and t(1;11)(q10;p10), both, novel cytogenetic abnormalities in a pediatric AML case	2
Lynch syndrome and Muir-Torre phenotype associated with a recurrent variant in the 3’UTR of the MSH6 gene	2
17. Deconvolution of genetic heterogeneity in Glioblastoma using multi-region sampling	2
Identification of KMT2A-ARHGEF12 fusion in a child with a high-grade B-cell lymphoma	2
Evaluation of hereditary/familial breast cancer patients with multigene targeted next generation sequencing panel and MLPA analysis in Turkey	2
RECQL4-related Rothmund-Thomson syndrome: A case series and literature review	2
20. Paternal UPD14 and sSMC derived from chromosome 14: A case report	2
Acute myeloid leukemia with LRRFIP1::FGFR1 rearrangement and a complex karyotype	2
Multi-omics inference of differential breast cancer-related transcriptional regulatory network gene hubs between young Black and White patients	2
Study on the use of Nanostring nCounter to analyze RNA extracted from formalin-fixed-paraffin-embedded and fresh frozen bladder cancer tissues [Cancer Genetics 268-269 (2022) 137-143]	2
Mutations of ARID1B, PIK3C2B, KMT2B, and FAT1 genes influence clinical outcome in newly diagnosed myeloma	2
Multi-region sequencing reveals genetic correlation between esophageal squamous cell carcinoma and matched cell-free DNA	2
8. A partial deletion of the EP300 gene detected by microarray in an individual with mild autism	2
A new four-way complex translocation variant involving the t(8;5;21;4)(q21;q13;q22;q31) and the relocalization of AML1/ETO fusion gene	2
61. Clinical whole exome/whole transcriptome analysis detects clinically relevant structural alterations in Multiple Myeloma	2
5. Further evidence of GABRA4 and TOP3B as autism susceptibility genes	2
Clinical management of three JMML siblings with germline CBL variation	2
A t(11;14)(q13;q32)/CCND1::IGH carrying progenitor germinal B-cell with subsequent cytogenetic aberrations contributes to the development of classic Hodgkin lymphoma	2
TRK inhibitor activity and resistance in TRK fusion-positive cancers in adults	2
34. A rare case of 46,XX/47,XXY mosaic Klinefelter syndrome in an infant	2
The clinical aspect of NTRK-fusions in pediatric papillary thyroid cancer	2
The hsa-miR-516a-5p and hsa-miR-516b-5p microRNAs reduce the migration and invasion on T98G glioblastoma cell line	2
Corrigendum to “Identification of a novel stemness-related signature with appealing implications in discriminating the prognosis and therapy responses for prostate cancer” [Cancer Genetics Volumes 276	2
Prognostic significance of CCND1 amplification/overexpression in smoking patients with esophageal squamous cell carcinoma	1
41. Participant reflections from the program for evaluation of Ashkenazi Jewish Cancer heritability involving the BRCA genes	1
Editorial Board	1
79. Extraction of multiple analytes in liquid biopsy may improve the diagnosis of breast cancer	1
99. Histopathologic Correlation Somatic Variants in Non Small Cell Lung Cancer with High Tumor Mutation Burden	1
14. Deletions resulting in Brachydactyly Mental Retardation Syndrome (BDMR): Multiple contributing regions in distal 2q37	1
109. Use of Bionano Optical Genome Mapping in a multi-platform structural variation analysis of a cancer reference cell line	1

53. Re-analysis of reported constitutional copy number variants using the newly published 2019 ACMG/ClinGen Technical Standards reveals few significant interpretation changes	1
Editorial Board	1
48. ALK tissue FISH in lung cancer: The MDACC experience	1
40. Correlation of histology, CCND1 over-expression, and CCND1 rearrangement in Renal Cell Carcinomas	1
15. Clinical validation of non-invasive prenatal screening using synthetic plasmas	1
6. Optical genome mapping as a potential Tier1 test for Postnatal Chromosomal Disorders – results of multi-institutional validation study of 331 retrospective clinical samples	1
High incidence of PI3K pathway gene mutations in South Indian cervical cancers	1
51. Remember breakpoint two. Enhancer swapping, a frequent deleterious consequence of balanced chromosomal rearrangements	1
A rare CALR variant mutation and efficient peginterferon alfa-2a response in a patient with essential thrombocythemia	1
105. Machine learning for automated tumor classification based on mutation repertoire	1
55. Clinical validation and implementation of exome, transcriptome and whole genome sequencing for pediatric cancers	1
33. Tumor cellularity estimation in a targeted NGS panel of tumor-only specimens expands analytical utility	1
38. Assessment of TRG and TRB clonality by NGS of dermatologic specimens is impacted by biopsy type, DNA and amplicon sizes	1
3. Application of optical genome mapping to identify samples with homologous recombination deficiency	1
47. Tumour-only NGS profiling: Application of data filters to identify candidate germline variants	1
74. Genetic and functional characterization of complex chromosomal rearrangements in a family with multisystem anomalies	1
Editorial Board	1
103. Formation of a ClinGen Variant Curation Expert Panel (VCEP) dedicated to Oncohistone H3 Variants in Pediatric Gliomas	1
87. A tale of two aspirates: sequential pulls of bone marrow yield discordant results in hepatosplenic T-cell lymphoma	1
126. MECOM rearrangement by Pericentric Inversion 3 presents a diagnostic challenge	1
24. Clinical utility of mate pair sequencing as a reflex test in B-lymphoblastic leukemia/lymphoma	1
Paediatric B lymphoblastic leukaemia with hyperdiploidy and a false-positive KMT2A fluorescence in situ hybridization result	1
45. Next-generation cytogenomic characterization of two complex prenatal cases by Saphyr's genome optical mapping	1
20. Increased Polo-like kinase 1 (Plk1) expression promotes centrosome amplification, chromosomal instability, and tumor formation in a mouse model	1
Unexpected appearance of KMT2A::MLLT10 fusion transcript in acute myeloid leukemia with t(5;11)(q31;q23.3)	1
28. Trisomy 21 silencing in hematopoietic and neural cells: New insights and prospects	1
2. Analytical tools to support detection of homologous recombination deficiency (HRD) using cytogenomic scar markers	1
Comprehensive analysis of PLKs expression and prognosis in breast cancer	1
103. Defining the pleiotropic GATA2 deficiency phenotype for the development of ACMG-AMP GATA2 variant curation rules	1
68. Orthogonal approaches to validate a knowledgebase of interpretations of clinically relevant somatic cancer variants	1
22. Characterization of atypical iAMP21 observed in B-Lymphoblastic Leukemia (B-ALL): A retrospective study from Mayo Clinic	1
102. Using cytogenomics to distinguish two types of renal cell carcinoma in a composite or collision tumor	1
46. Integrative cytogenetic and molecular studies unmasks `chromosomal mimicry' in hematologic malignancies	1
14. Concurrent systemic mastocytosis and T-lymphoblastic lymphoma unified by a novel cryptic JAKMIP2::PDGFRB rearrangement	1
37. Chromosomal microarray in the investigation of ASD: Diagnostic yield of 333 cases	1
4. Comprehensive next generation cytogenomics improves risk stratification of acute myeloid leukemia	1
55. CMA and concurrent karyotyping for MCA, ASD, and/or DD/ID patients: Cost effectiveness based on our 7-year experience	1
100. Identification of unique subtypes of pediatric high-grade glioma by comparative tumor transcriptomics	1
92. The ClinGen Somatic CDWG supports somatic variant curation and interpretation through structured guidance and procedures	1
82. Enabling large scale precision oncology research with a new standard for genomic variants: OMOP Genomic	1
RNA-Based next generation sequencing complements but does not replace fluorescence in situ hybridization studies for the classification of aggressive B-Cell lymphomas	1
129. Standardization of cancer terminology in the Mondo Disease Ontology	1
52. Variant classification versus variant interpretation: There is a difference	1
110. Discovery and characterization of novel fusions in Pediatric B-Lymphoblastic Leukemia (B-ALL)	1
36. Classifying benign multigenic CNVs: Exploring available population databases	1
11. Validation and implementation of BioDot instruments for semi-automated FISH slide processing	1
13. Remember breakpoint two: Enhancer swapping, a frequent deleterious consequence of balanced chromosomal rearrangements	1
Molecular profiling of osteosarcoma in children and adolescents from different age groups using a next-generation sequencing panel	1
104. A hematologic case with germline deletion of PMS2 and increased risk of HNPCC studied by optical genome mapping and NGS	1
Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature	1
84. Challenges in the clinical implementation of the large next-generation sequencing oncomine comprehensive plus assay	1
47. Optical genome mapping in hematological malignancy: Clinical outcomes in a 2-year follow-up retrospective study	1
25. Large scale analysis in Von Hippel-Lindau disease	1
33. Optical Genome Mapping identifies additional cytogenetic abnormalities in patients with hematologic malignancies	1
96. Dissection of the expressed actionable fusions' repertoire in solid tumors in a clinical setting across 14 cancer types	0
45. Clonal hematopoiesis in childhood cancer survivors	0
56. Chr8 gain is associated with MPNST transformation	0
40. Clonal evolution of Cutaneous T Cell Lymphoma (CTCL) revealed at single cell resolution	0
58. Implementing the ClinGen/CGC/VICC oncogenicity guidelines in a pediatric variant classification workflow	0
62. Profiling PIK3CA variants - a highlight of C2 domain variants in Disorders of Somatic Mosaicism	0
Editorial Board	0
35. Toward understanding the structure and function of the mammalian genome	0
Unraveling the Prognostic Role of t(1:19) in Pediatric Pre-B Acute Lymphoblastic Leukemia: Insights from a Saudi Nationwide Cohort	0
101. Molecular characterization of the antineoplastic effect of curcumin on acute myeloid leukemia cell lines	0
Editorial Board	0
Clinical whole-genome sequencing and FISH identify two different fusion partners for NUP98 in a patient with acute myeloid leukemia: A case report	0
Investigation of discordant sibling pairs from hereditary breast cancer families and analysis of a rare PMS1 variant	0
105. Clinical whole-genome sequencing identifies NSD3 as the correct fusion partner of NUP98 in a patient with acute myeloid	0
98. Utility and feasibility of Molecular Profiling of Circulating Tumor RNA (ctRNA) from FNA Supernatants	0
89. Identification of therapeutic combinations for immune checkpoint inhibitors (ICIs) using explanatory subgroup discovery	0
45. Deconstruction of pancreatic ductal adenocarcinoma identifies survival-associated tumor microenvironmental communities	0
33. Computational prediction of MHC anchor locations guide neoantigen identification and prioritization	0
44. An international landscape of cancer NGS reporting practices	0
10. New evidence for triplosensitivity of TBL1XR1	0
26. Improving interoperability of therapeutics and their targets for clinical and precision medicine applications	0
Diagnostic and prognostic potential of FBXO8 expression in kidney renal clear cell carcinoma and its regulation of renal adenocarcinoma cells	0
25. A new isogenic trisomy 21 iPSC resource	0
Impact of a haplotype (composed of the APC, KRAS, and TP53 genes) on colorectal adenocarcinoma differentiation and patient prognosis	0
94. Initial efforts of the ClinGen Solid Tumor Taskforce in promoting variant curation in solid tumors into CIViC	0
DNA repair and immune checkpoint blockade response	0
33. Triple Hit Follicular Lymphoma with MYC, BCL-2, and BCL-6 rearrangements, a case report	0
102. Elucidating the genomic landscape of Prostate Adenocarcinoma through whole genome and transcriptome sequencing	0
95. A novel comprehensive breakpoint-targeted assay for clinically actionable RNA fusions and aberrant RNAs in solid tumors	0
69. Integration of standards for variant oncogenicity into the CIViC data model	0
42. Laboratory and clinician collaboration yields results: Development of a comprehensive craniosynostosis genetic testing panel with a high diagnostic rate	0
84. Benefits of integrating an open-source knowledgebase in a precision oncology workflow	0
65. Insights into the genetic heterogeneity of glioblastoma: gene amplification in ecDNA and HSR	0
6. Genetic characterization of tetraploid/near-tetraploid acute myeloid leukemia patients	0
29. Real-world analysis of cytopenic patients for identification of Clonal Cytopenia(s) of Undetermined Significance (CCUS)	0
Machine learning analysis of CD4+ T cell gene expression in diverse diseases: insights from cancer, metabolic, respiratory, and digestive disorders	0
Editorial Board	0
A melanoma patient with macrophage-cancer cell hybrids in the primary tumor, a lymph node metastasis and a brain metastasis	0
77. Mining COSMIC for frameshift neoantigens as `off-the-shelf' therapeutic cancer vaccine candidates	0
41. Clinical significance of comprehensive genetic workup prior to use of assisted reproductive technology: A case study	0
39. Genomic microarray analysis reveals heterogeneity in high hyperdiploid B-cell acute lymphoblastic leukemia	0